Evidence map›Paper›PMID 24273586›Full record

ArticleDrug discovery today. Disease models2013

Changing the Scale and Efficiency of Chemical Warfare Countermeasure Discovery Using the Zebrafish.

Randall T Peterson, Calum A Macrae

Abstract read
In one paragraph

Article in Drug discovery today. Disease models, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Randall T PetersonHarvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital.
Calum A Macrae

Funding

Validating promising drug candidates in mammalian models of CN poisoningU54NS079201 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI PETERSON, RANDALL T, PETERSON, RAYMOND J · 2012 to 2016
$12.6M
Rapid development of in vivo models for countermeasure discovery: organophosphateU01NS063733 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI PETERSON, RANDALL T · 2008 to 2010
$1.2M
Unbiased screens in zebrafish for new classes of cyanide countermeasureU01NS063563 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MACRAE, CALUM A. · 2008 to 2011
$1.1M
NINDS NIH HHS U01 NS063563NINDS NIH HHS U01 NS063733NINDS NIH HHS U54 NS079201
6 · The paper itself

Abstract

As the scope of potential chemical warfare agents grows rapidly and as the diversity of potential threat scenarios expands with non-state actors, so a need for innovative approaches to countermeasure development has emerged. In the last few years, the utility of the zebrafish as a model organism that is amenable to high-throughput screening has become apparent and this system has been applied to the unbiased discovery of chemical warfare countermeasures. This review summarizes the in vivo screening approach that has been pioneered in the countermeasure discovery arena, and highlights the successes to date as well as the potential challenges in moving the field forward. Importantly, the establishment of a zebrafish platform for countermeasure discovery would offer a rapid response system for the development of antidotes to the continuous stream of new potential chemical warfare agents.

Identifiers

PMID24273586
PMCPMC3834265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.